Evidence map›Paper›PMID 22743675›Full record

ArticleThe European respiratory journal2012

Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.

Philip H Quanjer, Sanja Stanojevic, Tim J Cole, Xaver Baur, Graham L Hall, Bruce H Culver, Paul L Enright, John L Hankinson, Mary S M Ip, Jinping Zheng and 2 more

17 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The European respiratory journal, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 17 registered trials, which are not on this map. Cited by 2,794 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,794citing papers in PubMed, 2 pooled it
102.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02960503 phase1 / phase2withdrawnnot on this mapstarted 2016, after this paper: background citation

Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease: a Feasibility Trial

TypeinterventionalSponsorVanderbilt UniversityRan2016 to 2018Enrolled0ConditionsSickle Cell DiseaseArmsAzithromycin, Placebo
NCT03303586 narecruitingnot on this mapstarted 2017, after this paper: background citation

Investigating the Effects of Wearing Compression Stockings to Improve Asthma Symptoms at Night

TypeinterventionalSponsorUniversity Health Network, TorontoRan2017 to 2026Enrolled40ConditionsAsthmaArmsCompression Stockings, Control
NCT03324230 completednot on this mapstarted 2017, after this paper: background citation

Exacerbation Profile in Patients on Mepolizumab for Severe Refractory Eosinophilic Asthma- an Exploratory Study.

TypeobservationalSponsorQueen's University, BelfastRan2017 to 2019Enrolled146ConditionsAsthma Brittle
NCT04006964 completednot on this mapstarted 2018, after this paper: background citation

Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies

TypeobservationalSponsorRestech SrlRan2018 to 2022Enrolled579ConditionsRespiratory DiseaseArmsResmon PRO FULL v2
NCT04140825 completednot on this mapstarted 2018, after this paper: background citation

Within-Breath Total Respiratory Input Impedance in Healthy Adult Subjects

TypeobservationalSponsorRestech SrlRan2018 to 2022Enrolled231ConditionsRespiratory DiseaseArmsResmon PRO FULL
NCT04232579 unknown statusnot on this mapstarted 2020, after this paper: background citation

Diagnosis of Asthma, COPD and ACO in Vietnamese Context, Proposal of a Therapeutic Strategy Compatible With the Guidelines and Development of Predictive Biomarkers of the Response to Treatment

TypeobservationalSponsorOlivier MichelRan2020 to 2022Enrolled600ConditionsChronic Obstructive Respiratory DiseasesArmsTherapeutic strategy
NCT04320342 phase3completednot on this mapstarted 2022, after this paper: background citation

A Phase III, 52-week, Multinational, Multicenter, Randomized, Double-blind, 2-arm Parallel Group Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate Plus Glycopyrronium Bromide (CHF 5993) With the Fixed Dose Dual Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate (CHF 1535), Both Administered Via pMDI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

TypeinterventionalSponsorChiesi Farmaceutici S.p.A.Ran2022 to 2026Enrolled3,433ConditionsCOPD, COPD ExacerbationArmsBeclomethasone Dipropionate, Glycopyrronium Bromide, Formoterol Fumarate
NCT04579055 nacompletednot on this mapstarted 2020, after this paper: background citation

The Impact of Chair Seat Height on the 1-Minute Sit to Stand Test Performance in Chronic Obstructive Pulmonary Disease: a Randomized Cross-over Study

TypeinterventionalSponsorThomas RieglerRan2020 to 2021Enrolled55ConditionsCOPD, Chronic Obstructive Pulmonary DiseaseArms1-min STS test: adjusted, 1-min STS test: standardized
NCT05009758 narecruitingnot on this mapstarted 2021, after this paper: background citation

Moving Towards PREcision Medicine In United Airways Disease: Unraveling inflaMmatory Patterns in Asthmatic Patients With or Without Nasal Polyps (PREMIUM) - a Descriptive Pilot Study

TypeinterventionalSponsorMedical University of ViennaRan2021 to 2026Enrolled30ConditionsAsthma, Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis), Nasal PolypsArmsBlood sampling, Nasosorption, Oral sampling, Bronchoscopy, Nasal biopsy
NCT05292586 phase3completednot on this mapstarted 2022, after this paper: background citation

A 12 Week, Randomized, Double-blind, Multicenter, Active Controlled, 2-Arm Parallel Group Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose (Fixed Combination of Extrafine Beclomethasone Dipropionate Plus Formoterol Fumarate) Compared to CHF 718 pMDI 800µg Total Daily Dose (Extrafine Beclomethasone Dipropionate) in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid

TypeinterventionalSponsorChiesi Farmaceutici S.p.A.Ran2022 to 2024Enrolled1,377ConditionsAsthmaArmsBeclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate
NCT05632666 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Respiratory Muscle Training in Patients With Spinal Muscular Atrophy (SMA).

TypeinterventionalSponsorUMC UtrechtRan2021 to 2023Enrolled30ConditionsSpinal Muscular AtrophyArmsInspiratory and expiratory muscle training at a therapeutic intensity, Inspiratory and expiratory muscle training at a non-therapeutic intensity
NCT05850494 phase3completednot on this mapstarted 2023, after this paper: background citation

Randomized, DB, Crossover Study to Assess Bronchospasm Potentially Induced by HFO MDI vs. HFA MDI Propellant in Participants With Asthma Well/Partially Controlled on SABA With or Without Low-Dose ICS

TypeinterventionalSponsorAstraZenecaRan2023 to 2023Enrolled52ConditionsAsthmaArmsHFA MDI, HFO MDI
NCT06919185 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Short- and Long-term Effects of Robot-assisted Plication in Diaphragmatic Paralysis - the Prospective RAPIDLY-study

TypeobservationalSponsorUppsala County Council, SwedenRan2025 to 2031Enrolled50ConditionsDiaphragmatic Plication, Diaphragmatic Paralysis, Diaphragmatic Eventration
NCT07018076 recruitingnot on this mapstarted 2025, after this paper: background citation

Candidate Clinical Correlate of Prognostic Outcome for TB Study

TypeobservationalSponsorUniversity of California, San FranciscoRan2025 to 2027Enrolled750ConditionsTuberculosisArmsRS ratio, Blood-based host immune response assays
NCT07053839 nacompletednot on this mapstarted 2023, after this paper: background citation

Effect of the Visual Reminder "AdhasText" on Adherence to Inhaled Corticosteroids, Symptom Control, and Pulmonary Function in Children With Asthma: A Randomized Clinical Trial

TypeinterventionalSponsorROXANA AZNARAN TORRESRan2023 to 2024Enrolled64ConditionsAsthma in ChildrenArmsDaily Text Reminder
NCT07088926 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

A Phase IIb Randomized, Double-blind, Placebo-controlled, Parallel, Multidose Study to Evaluate the Efficacy, Safety, and PK of AZD0292 in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

TypeinterventionalSponsorAstraZenecaRan2025 to 2028Enrolled435ConditionsBronchiectasis With Pseudomonas Aeruginosa ColonizationArmsAZD0292, Placebo
NCT07573098 narecruitingnot on this mapstarted 2025, after this paper: background citation

Digital Tool for Improved Self-management of COPD

TypeinterventionalSponsorBjörn NordlundRan2025 to 2027Enrolled50ConditionsCOPDArmsCOPD treatment check
3 · Its place in the literature

Who cites it

2,794 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5,708 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Pulmonary function test parameters before liver transplantation predict post-transplant survival and respiratory-related death.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2026
    Article
  17. Pre-COPD, PRISm, and COPD in young adults born preterm.Annals of the American Thoracic Society · 2026
    Article
  18. Article
  19. Article
  20. Article

2,734 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Philip H QuanjerDept of Pulmonary Diseases and Dept of Paediatrics, Erasmus Medical Centre, Erasmus University, Rotterdam, the Netherlands.
Sanja Stanojevic
Tim J Cole
Xaver Baur
Graham L Hall
Bruce H Culver
Paul L Enright
John L Hankinson
Mary S M Ip
Jinping Zheng
Janet Stocks
ERS Global Lung Function Initiative
Erasmus MC · NL

Funding

Pulmonary microvascular perfusion in the Multi-Ethnic Study of AtherosclerosisR01HL077612 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI R Graham BARR · 2004 to 2026
$18.8M
Adjunctive Use of Apyrase to Fibrinolytic TherapyR44HL095169 · NHLBI · APT THERAPEUTICS, INC. · PI CHEN, RIDONG · 2012 to 2013
$1.3M
SUBCLINICAL CARDIOVASCULAR DISEASE COORDINATING CENTER-N01HC95159-268095159N01HC095159 · HC · UNIVERSITY OF WASHINGTON · PI KRONMAL, RICHARD A · 1999 to 2006
$304k
Adjunctive Use of Apyrase to Fibrinolytic TherapyR43HL095169 · NHLBI · APT THERAPEUTICS, INC. · PI CHEN, RIDONG · 2009 to 2009
$226k
SUBCLINICAL CARDIOVASCULAR DISEASE STUDY--EBCT READINGN01HC095169 · HC · LA BIOMED RES INST/ HARBOR UCLA MED CTR · PI DETRANO, ROBERT · 1999 to 2001
$124k
Medical Research Council G0400546Medical Research Council G0700961Medical Research Council MR/J004839/1NHLBI NIH HHS N01 HC095159NHLBI NIH HHS N01-HC095159-165NHLBI NIH HHS N01 HC095169NHLBI NIH HHS N01-HC095169NHLBI NIH HHS R01 HL077612NHLBI NIH HHS R01-HL077612
6 · The paper itself

Abstract

The aim of the Task Force was to derive continuous prediction equations and their lower limits of normal for spirometric indices, which are applicable globally. Over 160,000 data points from 72 centres in 33 countries were shared with the European Respiratory Society Global Lung Function Initiative. Eliminating data that could not be used (mostly missing ethnic group, some outliers) left 97,759 records of healthy nonsmokers (55.3% females) aged 2.5-95 yrs. Lung function data were collated and prediction equations derived using the LMS method, which allows simultaneous modelling of the mean (mu), the coefficient of variation (sigma) and skewness (lambda) of a distribution family. After discarding 23,572 records, mostly because they could not be combined with other ethnic or geographic groups, reference equations were derived for healthy individuals aged 3-95 yrs for Caucasians (n=57,395), African-Americans (n=3,545), and North (n=4,992) and South East Asians (n=8,255). Forced expiratory value in 1 s (FEV(1)) and forced vital capacity (FVC) between ethnic groups differed proportionally from that in Caucasians, such that FEV(1)/FVC remained virtually independent of ethnic group. For individuals not represented by these four groups, or of mixed ethnic origins, a composite equation taken as the average of the above equations is provided to facilitate interpretation until a more appropriate solution is developed. Spirometric prediction equations for the 3-95-age range are now available that include appropriate age-dependent lower limits of normal. They can be applied globally to different ethnic groups. Additional data from the Indian subcontinent and Arabic, Polynesian and Latin American countries, as well as Africa will further improve these equations in the future.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsChildChild, PreschoolEthnicityFemaleForced Expiratory VolumeGlobal HealthHumansLungMaleMiddle AgedModels, Statistical

Identifiers

PMID22743675
PMCPMC3786581
OpenAlexW2099449365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

and 11 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.